Modeling chromosomal translocations using conditional alleles to recapitulate initiating events in human leukemias.

Recurrent reciprocal chromosomal translocations are present in more than 50% of leukemias. A deeper understanding of how they affect cancer initiation is essential for evaluating the origins of cancer and the potential for therapy based on the translocation products. Mouse models of chromosomal translocations are required for this. Here we summarize three methodologies developed in our laboratory to model chromosomal translocations (knock-in, translocator, and invertor methods). We have used these models to study leukemias caused by fusions of the mixed lineage leukemia (MLL) gene and the Ews-ERG fusion gene to evaluate oncogenicity and elucidate some general principles about translocation products. We show that MLL fusions have the capacity to cause hematopoietic tumors only if expressed in permissive cells and that the Mll-Enl fusion can cause lineage reassignment if the chromosomal translocation occurs in lineage noncommitted progenitors. The leukemia-initiating cells generated by Mll fusions or by Ews-ERG fusion can be committed cells within the hematopoietic pathway. Our translocation mimic models are applicable to any human reciprocal chromosomal translocation.

[1]  N. Kirchhof,et al.  A murine Mll-AF4 knock-in model results in lymphoid and myeloid deregulation and hematologic malignancy. , 2006, Blood.

[2]  T. Rabbitts,et al.  A conditional model of MLL-AF4 B-cell tumourigenesis using invertor technology , 2006, Oncogene.

[3]  T. Rabbitts,et al.  Mll fusions generated by Cre‐loxP‐mediated de novo translocations can induce lineage reassignment in tumorigenesis , 2005, The EMBO journal.

[4]  T. Rabbitts,et al.  The Ews-ERG Fusion Protein Can Initiate Neoplasia from Lineage-Committed Haematopoietic Cells , 2005, PLoS biology.

[5]  T. Rabbitts,et al.  Extending the repertoire of the mixed-lineage leukemia gene MLL in leukemogenesis. , 2004, Genes & development.

[6]  T. Rabbitts,et al.  The LMO2 T-Cell Oncogene Is Activated via Chromosomal Translocations or Retroviral Insertion during Gene Therapy but Has No Mandatory Role in Normal T-Cell Development , 2003, Molecular and Cellular Biology.

[7]  T. Rabbitts,et al.  Engineering de novo reciprocal chromosomal translocations associated with Mll to replicate primary events of human cancer. , 2003, Cancer cell.

[8]  T. Rabbitts,et al.  The promiscuous MLL gene links chromosomal translocations to cellular differentiation and tumour tropism. , 2002, Trends in molecular medicine.

[9]  N. Harris,et al.  Bethesda proposals for classification of lymphoid neoplasms in mice. , 2002, Blood.

[10]  C. Pui,et al.  Outcome of treatment in childhood acute lymphoblastic leukaemia with rearrangements of the 11q23 chromosomal region , 2002, The Lancet.

[11]  J. Downing,et al.  Expression of a conditional AML1-ETO oncogene bypasses embryonic lethality and establishes a murine model of human t(8;21) acute myeloid leukemia. , 2002, Cancer cell.

[12]  J. Rowley,et al.  Chromosome translocations: dangerous liaisons revisited , 2001, Nature Reviews Cancer.

[13]  C. Sawyers,et al.  Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia. , 2001, The New England journal of medicine.

[14]  M. Capecchi.  Choose your target , 2000, Nature Genetics.

[15]  E. Simpson,et al.  Inter‐chromosomal recombination of Mll and Af9 genes mediated by cre‐loxP in mouse development , 2000, EMBO reports.

[16]  T. Rabbitts,et al.  Tumorigenesis in mice with a fusion of the leukaemia oncogene Mll and the bacterial lacZ gene , 2000, The EMBO journal.

[17]  T. Rabbitts,et al.  The oncogenic LIM-only transcription factor Lmo2 regulates angiogenesis but not vasculogenesis in mice. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[18]  T. Rabbitts,et al.  The Mll–AF9 gene fusion in mice controls myeloproliferation and specifies acute myeloid leukaemogenesis , 1999, The EMBO journal.

[19]  M. Marín‐Padilla,et al.  Embryonic lethality and impairment of haematopoiesis in mice heterozygous for an AML1-ETO fusion gene , 1997, Nature Genetics.

[20]  C. Wijmenga,et al.  Failure of Embryonic Hematopoiesis andLethal Hemorrhages in Mouse Embryos Heterozygousfor a Knocked-In Leukemia Gene CBFB–MYH11 , 1996, Cell.

[21]  T. Rabbitts,et al.  An Mll–AF9 Fusion Gene Made by Homologous Recombination Causes Acute Leukemia in Chimeric Mice: A Method to Create Fusion Oncogenes , 1996, Cell.

[22]  R. Perlmutter,et al.  Functional dissection of the murine lck distal promoter. , 1995, Journal of immunology.

[23]  M. Fornerod,et al.  Cre-mediated site-specific translocation between nonhomologous mouse chromosomes. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[24]  P. Chambon,et al.  Conditional site-specific recombination in mammalian cells using a ligand-dependent chimeric Cre recombinase. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[25]  M. Gossen,et al.  Transcriptional activation by tetracyclines in mammalian cells. , 1995, Science.

[26]  B. Kwabi-Addo,et al.  A site–directed chromosomal translocation induced in embryonic stem cells by Cre-loxP recombination , 1995, Nature Genetics.

[27]  T. Rabbitts,et al.  Chromosomal translocations in human cancer , 1994, Nature.

[28]  M. Evans,et al.  The Oncogenic Cysteine-rich LIM domain protein Rbtn2 is essential for erythroid development , 1994, Cell.

[29]  Y. Hayashi,et al.  An RNA-binding protein gene, TLS/FUS, is fused to ERG in human myeloid leukemia with t(16;21) chromosomal translocation. , 1994, Cancer research.

[30]  Y. Hayashi,et al.  An ets-related gene, ERG, is rearranged in human myeloid leukemia with t(16;21) chromosomal translocation. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[31]  S. Cory,et al.  Transgenic models of tumor development. , 1991, Science.

[32]  T. Rabbitts.  Translocations, master genes, and differences between the origins of acute and chronic leukemias , 1991, Cell.

[33]  J. Rowley.  A New Consistent Chromosomal Abnormality in Chronic Myelogenous Leukaemia identified by Quinacrine Fluorescence and Giemsa Staining , 1973, Nature.

[34]  T. Rabbitts,et al.  The invertor knock-in conditional chromosomal translocation mimic , 2004, Nature Methods.